FFR medical abbreviation refers to fractional flow reserve, a hemodynamic measurement used during coronary angiography to assess the severity of a coronary stenosis. This index helps clinicians decide whether a lesion is physiologically significant and likely to benefit from revascularization.
Understanding the role, methodology, and limitations of FFR supports safer treatment planning and better patient outcomes in individuals with suspected or confirmed obstructive coronary artery disease. The following sections explain key contexts, clinical evidence, and practical considerations around this widely adopted metric.
| Parameter | Definition | Typical Threshold | Clinical Implication |
|---|---|---|---|
| FFR | Ratio of maximum blood flow in a diseased vessel to maximum flow in a normal vessel | ≤ 0.80 | Likely functionally significant; may benefit from revascularization |
| iFR | Instantaneous wave-free ratio, measured during diastole without vasoactive drugs | ≤ 0.89 | Alternative to FFR without adenosine or dobutamine |
| Coronary Stenosis | Diameter narrowing seen on angiography | ≥ 50% | Anatomic severity alone does not always indicate ischemia |
| Revascularization | Percutaneous coronary intervention or coronary artery bypass grafting | Guided by FFR ≤ 0.80 | Improves outcomes when functionally significant lesions are treated |
How FFR Measurement is Performed in Catheterization Labs
During cardiac catheterization, a guiding catheter is engaged at the aorta, and a Doppler or pressure-sensor wire is advanced across the target stenosis. The measurement compares distal coronary pressure to aortic pressure under conditions of maximal vasodilation.
Pharmacologic hyperemia is usually induced by intravenous adenosine or regadenoson to equalize flow between the vessel territories being compared. Technicians must ensure adequate sedation, monitor hemodynamics, and verify that standardized hyperemia is achieved to avoid misclassification of the lesion.
Operators also consider calibration checks, wire positioning, and the presence of collaterals that could alter pressure readings. Adherence to standardized protocols minimizes variability and supports reproducibility across centers and operators.
Clinical Evidence Supporting FFR-Guided PCI
Multiple randomized trials have shown that FFR-guided percutaneous coronary intervention reduces unnecessary stenting, lowers rates of repeat revascularization, and maintains low major adverse cardiac event rates. These data underpin widespread adoption of physiologic assessment in current guidelines.
Cost-effectiveness analyses indicate that routine FFR measurement can decrease procedural volume and healthcare expenditures by avoiding interventions on borderline lesions. Resource allocation should account for both equipment and trained personnel to maximize value.
Real-world registries reinforce trial findings, demonstrating consistent benefit when FFR criteria are applied systematically across diverse patient populations and healthcare systems.
Limitations and Pitfalls of FFR Assessment
Technical factors such as arrhythmia, proximal disease, or anomalous coronary anatomy can complicate accurate FFR measurement. Operator experience, proper wire positioning, and attention to hemodynamic stability are critical for reliable results.
Physiologic assessment with FFR should not replace a thorough angiographic evaluation; instead, it complements anatomic findings to refine revascularization strategy. Multimodality imaging and integrated decision-making enhance accuracy in complex lesions.
Understanding limitations promotes appropriate use, avoiding overreliance on a single numeric threshold and encouraging individualized treatment plans based on clinical, anatomic, and physiologic data.
Integration with Modern Imaging and Alternative Metrics
Intravascular ultrasound, optical coherence tomography, and computational fluid dynamics can provide additional anatomic and functional information that complements FFR. Hybrid approaches refine lesion characterization and support more precise intervention strategies.
Alternatives such as iFR or resting pressure-derived metrics allow assessment without adenosine, which may benefit patients in whom adenosine is contraindicated or poorly tolerated. These options expand physiologic testing in real-world practice.
Careful selection of patients and lesion types ensures that advanced technologies and alternative metrics add value without unnecessary complexity or cost escalation.
Practical Recommendations for FFR Use in Coronary Care
- Use FFR to guide revascularization when anatomic stenosis and clinical presentation are discordant.
- Follow standardized protocols for hyperemia induction, pressure wire positioning, and data interpretation.
- Consider alternative physiologic indices or imaging when adenosine is contraindicated.
- Engage a multidisciplinary team for borderline or complex lesions to align treatment with patient goals.
FAQ
Reader questions
Is FFR the same as measuring percent stenosis on a coronary angiogram?
No, FFR measures blood flow dynamics and physiologic significance, while percent stenosis reflects anatomic narrowing seen on imaging; both are needed for comprehensive decision-making.
Can FFR be performed without using adenosine or regadenoson?
Yes, iFR and other wave-intensity methods can assess ischemia without pharmacologic hyperemia, but the clinical context and local expertise should guide technique selection.
What happens if the FFR value is near the cutoff, such as 0.78 to 0.82?
Values near the threshold should prompt careful integration with symptoms, anatomic features, and downstream ischemia risk; a multidisciplinary team approach often clarifies the best strategy.
Are there safety concerns specific to patients with poor kidney function or diabetes?
Yes, these patients may have microvascular disease or contraindications to adenosine; individualized planning, alternative hyperemic agents, and adjunctive imaging help optimize safety and accuracy.